Manuel Benedikt Graeber

Manuel Benedikt Graeber's AcademicInfluence.com Rankings

Biology

#11110

World Rank

#14485

Historical Rank

Genetics

#1187

World Rank

#1287

Historical Rank

Neuroscience

#1782

World Rank

#1838

Historical Rank

biology Degrees

Download Badge

Biology

Manuel Benedikt Graeber's Degrees

PhD Neuroscience University of California, San Francisco
Bachelors Biology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Manuel Benedikt Graeber Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Manuel Benedikt Graeber's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease (1998) (2454)
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. (1998) (2074)
Functional plasticity of microglia: A review (1988) (970)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease (2010) (699)
Changing Face of Microglia (2010) (570)
Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells (1988) (379)
Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium (2008) (371)
Microglia in brain tumors (2002) (358)
Role of microglia in CNS inflammation (2011) (336)
Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy (1988) (331)
The facial nerve axotomy model (2004) (308)
Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury (1989) (294)
Identity of ED2‐positive perivascular cells in rat brain (1989) (283)
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition (2005) (264)
The molecular profile of microglia under the influence of glioma. (2012) (245)
Biomarkers for Parkinson's disease (2009) (229)
New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury (1990) (220)
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease (2006) (206)
Microglia: Immune Network in the CNS (1990) (201)
Surveillance, intervention and cytotoxicity: is there a protective role of microglia? (1994) (197)
Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system (1989) (197)
Oligodendrogliomas: Reproducibility and Prognostic Value of Histologic Diagnosis and Grading (2001) (194)
Positron emission tomography and functional characterization of a complete PBR/TSPO knockout (2014) (194)
The case described by Alois Alzheimer in 1911 (1998) (191)
The microglial cytoskeleton: vimentin is localized within activated cellsin situ (1988) (184)
Delayed astrocyte reaction following facial nerve axotomy (1988) (180)
The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging (2008) (172)
The microglia/macrophage response in the neonatal rat facial nucleus following axotomy (1998) (165)
Transformation of donor‐derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy (2001) (164)
On the question of apoptosis in the parkinsonian substantia nigra (1997) (153)
Microglial Activation in Alzheimer Disease: Association with APOE Genotype (1998) (152)
Ultrastructural Location of Major Histocompatibility Complex (MHC) Class II Positive Perivascular Cells in Histologically Normal Human Brain (1992) (152)
Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium (2009) (149)
Cellular pathology of the central nervous system. (2002) (142)
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. (2009) (128)
Mechanisms of Cell Death in Neurodegenerative Diseases: Fashion, Fiction, and Facts (2002) (125)
Neuronal FasL Induces Cell Death of Encephalitogenic T Lymphocytes (2000) (120)
Electron microscopy of tissue adherent to explanted electrodes in dystonia and Parkinson's disease. (2004) (111)
Striatal &bgr;-Amyloid Deposition in Parkinson Disease With Dementia (2008) (105)
Microglia and microglia-derived brain macrophages in culture: generation from axotomized rat facial nuclei, identification and characterization in vitro (1989) (105)
Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium (2006) (102)
The medial and lateral substantia nigra in Parkinson’s disease: mRNA profiles associated with higher brain tissue vulnerability (2007) (101)
Microglia states and nomenclature: A field at its crossroads (2022) (99)
Glutathione relates to neuropsychological functioning in mild cognitive impairment (2014) (98)
Microglia and the Development of Spongiform Change in Creutzfeldt-Jakob Disease (1998) (95)
Synaptic stripping in the human facial nucleus (2004) (94)
Development of ramified microglia from early macrophages in the zebrafish optic tectum (2013) (93)
Immunoelectron microscopic localization of laminin in normal and regenerating mouse sciatic nerve (1990) (92)
CR3/43, a marker for activated human microglia: application to diagnostic neuropathology (1994) (92)
Recent developments in the molecular genetics of mitochondrial disorders (1998) (90)
Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease (1996) (89)
Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease (1998) (88)
Perivascular microglia defined (1990) (87)
Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation (2008) (86)
Microglia only weakly present glioma antigen to cytotoxic T cells (1999) (86)
Increase of transferrin receptors and iron uptake in regenerating motor neurons (1989) (82)
Association of the mitochondrial tRNAA4336G mutation with Alzheimer's and Parkinson's diseases (1997) (80)
Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients. (1999) (79)
A presenilin 1 mutation in the first case of Alzheimer's disease (2013) (78)
Role of Mitochondria in Parkinson Disease (1999) (74)
Population control of microglia: does apoptosisplay a role? (1997) (74)
Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D. (1998) (73)
Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies. (2009) (72)
Correction: Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition (2006) (70)
Neuronal pentraxin II is highly upregulated in Parkinson’s disease and a novel component of Lewy bodies (2007) (65)
Immunophenotypic characterization of rat brain macrophages in culture (1989) (62)
The need to unify neuropathological assessments of vascular alterations in the ageing brain Multicentre survey by the BrainNet Europe consortium (2012) (60)
‘Neuroinflammation’ differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared (2014) (59)
Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases. (1997) (59)
Comparative study of commercially available anti‐α‐synuclein antibodies (2006) (58)
Towards a transcriptome definition of microglial cells (2004) (56)
Contralateral early blink reflex in patients with facial nerve palsy: indication for synaptic reorganization in the facial nucleus during regeneration (1992) (54)
Nucleo-cytoplasmic transport of TDP-43 studied in real time: impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons (2018) (53)
Monocyte-Astrocyte Networks Regulate Matrix Metalloproteinase Gene Expression and Secretion in Central Nervous System Tuberculosis In Vitro and In Vivo1 (2007) (52)
Delineation of the dystonia-parkinsonism syndrome locus in Xq13. (1992) (51)
The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions. (1996) (51)
Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy (2014) (49)
Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy‐body Parkinsonism (1996) (49)
5'-Nucleotidase in postnatal ontogeny of rat cerebellum: a marker for migrating nerve cells? (1988) (48)
No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease. (1994) (44)
Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease (1999) (44)
Multiple mechanisms of microglia: A gatekeeper's contribution to pain states (2012) (42)
Dystonia-parkinsonism syndrome (XDP) locus: flanking markers in Xq12-q21.1. (1992) (39)
Regional heterogeneity of mtDNA heteroplasmy in parkinsonian brain. (1996) (38)
IFN' synergizes with IL‐1α to up‐regulate MMP‐9 secretion in a cellular model of central nervous system tuberculosis (2007) (37)
Neurodegeneration and aging: Role of the second genome (1998) (35)
Quantitative immunohistochemistry in the rat facial nucleus with [125I]-iodinated secondary antibodies and in situ autoradiography: non-linear binding characteristics of primary monoclonal and polyclonal antibodies. (1993) (34)
The role of glia in late-life depression (2012) (34)
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline (2019) (33)
Synaptic 5'-nucleotidase is transient and indicative of climbing fiber plasticity during the postnatal development of rat cerebellum. (1991) (31)
Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction (2004) (31)
Genotype-Phenotype Correlation in Gemistocytic Astrocytomas (2001) (30)
Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. (1997) (30)
Microglia in Culture: What Genes Do They Express? (2004) (29)
MICROGLIA IN GEMISTOCYTIC ASTROCYTOMAS (2007) (29)
The microglial gene regulatory network activated by interferon-gamma (2007) (28)
Neuroinflammation: No Rose by Any Other Name (2014) (25)
Reaction on Motoneurons and Their Microenvironment to Axotomy (1986) (24)
Expression of alpha-synuclein in non-apoptotic, slowly degenerating facial motoneurones (2001) (24)
The third glial cell type, the microglia: cellular markers of activation in situ. (1990) (24)
Parkinson disease: analysis of mitochondrial DNA in monozygotic twins (2000) (23)
Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium (2014) (23)
The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring (2019) (23)
Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continents (2001) (21)
Absence of the mitochondrial A7237T mutation in Parkinson's disease. (1995) (21)
Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease. (1999) (20)
Defining Microglial States and Nomenclature: A Roadmap to 2030 (2022) (20)
The expression of growth factor receptors during nerve regeneration. (1990) (20)
The X‐Linked Dystonia‐Parkinsonism Syndrome (XDP): Clinical and Molecular Genetic Analysis (1992) (19)
Light and electron microscopical immunocytochemistry of 5′-nucleotidase in rat cerebellum (2004) (19)
Emergent Properties of Microglia (2014) (19)
Evidence against a reliable staging system of α‐synuclein pathology in Parkinson's disease (2009) (19)
Fine mapping of the human SCIDX1 locus at Xq12-13.1. (1993) (18)
Microglial rod cells. (1994) (17)
Twenty-first century brain banking: at the crossroads (2008) (16)
Molecular basis and diagnosis of neurogenetic disorders (1994) (16)
Dementia with Lewy bodies: disease concept and genetics (2003) (15)
In vitro proliferation of axotomized rat facial nucleus‐derived activated microglia in an autocrine fashion (2006) (14)
Striatal β-Amyloid Deposition in Parkinson Disease With Dementia. Authors' reply (2008) (14)
The potential for genetically altered microglia to influence glioma treatment. (2013) (13)
Perivascular location and phenotypic heterogeneity of microglial cells in the rat brain (1991) (12)
Non‐Radioactive Direct Sequencing of PCR Products Amplified from Neuropathological Specimens (1993) (11)
The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation Fog. (2018) (10)
The α1-antichymotrypsin A-allele in German Parkinson disease patients (1999) (10)
Bone marrow-derived microglia in pilocytic astrocytoma. (2011) (10)
Cytokine Signalling at the Microglial Penta-Partite Synapse (2021) (9)
Alois Alzheimer's case, Auguste D., did not carry the N141I mutation in PSEN2 characteristic of Alzheimer disease in Volga Germans. (2011) (9)
Selective, high-contrast detection of syngeneic glioblastoma in vivo (2020) (9)
Structural Plasticity in Lesioned Motoneurons (1988) (8)
Synapses, Microglia, and Lipids in Alzheimer’s Disease (2022) (8)
Global democratic consensus on neuropathological disease criteria (2002) (7)
Wavelet analysis of gene expression (WAGE) (2004) (7)
Parkinson disease: extranigral, multisystem, and {alpha}-synuclein "plus". (2009) (7)
Genetics of neuroinflammation in Alzheimer disease (1999) (7)
Nuclear Hormone and Orphan Receptors: Their Role in Neuronal Differentiation and Cytoprotection and in the Pathogenesis of Parkinson’s Disease (2003) (6)
Microglioma in a child - a further case in support of the microglioma entity and distinction from histiocytic sarcoma. (2016) (6)
Towards a molecular definition of microglia (2002) (6)
Microglia, macrophages and the blood-brain barrier. (1993) (6)
Up-regulation of matrix metallopeptidase 12 in motor neurons undergoing synaptic stripping (2014) (5)
The role of astrocytes in facial nerve regeneration. (1994) (5)
Association between ACT polymorphism and Alzheimer's disease. (1998) (5)
A Free Community Approach to Classifying Disease (2004) (5)
Microglia morphophysiological diversity and its implications for the CNS (2022) (5)
What does apoptosis have to do with Parkinson's disease? (1999) (5)
A Bifocal Classification and Fusion Network for Multimodal Image Analysis in Histopathology (2020) (4)
PathoFusion: An Open-Source AI Framework for Recognition of Pathomorphological Features and Mapping of Immunohistochemical Data (2021) (4)
ORIGINAL ARTICLE Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis (1997) (3)
Calcium–axonemal microtubuli interactions underlie mechanism(s) of primary cilia morphological changes (2018) (3)
Transformation of bone marrow-derived macrophages into ramified microglia during autoimmune inflammation of the axotomized rat facial nucleus (1998) (3)
Ground state depletion microscopy as a tool for studying microglia–synapse interactions (2020) (3)
Development of the microglia literature. (1994) (3)
Isolation of DNTR polymorphisms from yeast artificial chromosomes encompassing X chromosomal loci PGK1 and DXS56 (1992) (3)
The 3rd German-Japanese Joint Workshop. Cell Death in the CNS: Molecules and Programs (1996) (2)
[The apolipoprotein E gene and Alzheimer disease phenotype]. (1995) (2)
Evidence for a Growing Involvement of Glia in Amyotrophic Lateral Sclerosis (2021) (2)
Automated Machine-Learning Framework Integrating Histopathological and Radiological Information for Predicting IDH1 Mutation Status in Glioma (2021) (2)
Depthwise Multiception Convolution for Reducing Network Parameters without Sacrificing Accuracy (2020) (2)
Workshop 11: Microglia, Cell of the Brain Decade (1994) (2)
A new approach to the genetic analysis of nervous system diseases: retrospective genotyping of archival brains. (1998) (2)
Regulation of transferrin receptors and iron uptake in normal and injured nervous system. (1994) (2)
The alpha1-antichymotrypsin A-allele in German Parkinson disease patients. (1999) (2)
Antigen Presentation at the Blood-Brain Barrier: A Role for Astrocytes? (1993) (2)
Sequence analysis of the MTCYB gene in Parkinson disease (2000) (2)
Publication of microarray results (2003) (2)
Expression profiling of the parkinsonian substantia nigra using microarrays (2004) (1)
Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking. (2019) (1)
Translating the cellular neuropathology of microglia into neuroimaging results (2004) (1)
Four dinucleotide repeat polymorphisms at the D7S804 locus. (1993) (1)
Microglia and gliomas may have a symbiotic relationship (2004) (1)
Cellular Biology of the Experimental Peripheral Nerve Lesion (1990) (1)
OLIGODENDROGLIOMAS: REPRODUCIBILITY OF GRADING PARAMETERS (1999) (1)
An Open-Source AI Framework for the Analysis of Single Cells in Whole-Slide Images with a Note on CD276 in Glioblastoma (2022) (1)
A European Board Examination in Neuropathology (2007) (1)
Nonradioactive PCR sequencing using digoxigenin. (1996) (1)
Glial Cells: Microglia during Normal Brain Aging (2009) (1)
Glial activity and convergence of pathological pathways in Lewy Body parkinsonism (2004) (0)
Contents Vol. 25, 2003 (2004) (0)
‘Neuroinflammation’ differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared (2014) (0)
1-29-15 Sequence analysis of mitochondrial complex I genes in 23 Parkinson's disease patients (1997) (0)
Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy (2013) (0)
Microglia and Brain Macrophages as Drivers of Glioma Progression (2022) (0)
Subject Index Vol. 25, 2003 (2004) (0)
Response from Authors (2008) (0)
Developing the field of neurogenetics (2017) (0)
The motoneuron and its microenvironment reacting to axonal lesions (1989) (0)
ABSENCE OF APOE e4 ALLELE IN THE NEUROFIBRILLARY TANGLE SUBSET OF SENILE DEMENTIA (1997) (0)
Poster Session 32: Degenerative Disease ll (1994) (0)
XIIIth International Congress of Neuropathology 7-12 September 1997, Perth, Western Australia. (2006) (0)
Online First publication (2001) (0)
Alzheimerʼs disease, Parkinsonʼs disease and schizophrenia are not inflammatory diseases while inflammation is recognizable beyond organ borders (2015) (0)
Glial Cells: Microglia (2019) (0)
Towards an immunological definition of the blood-brain barrier: significane of major hisotcompatibity complex class II-positve perivascular cells (1992) (0)
Tuberculosis In Vitro and In Vivo and Secretion in Central Nervous System Matrix Metalloproteinase Gene Expression Monocyte-Astrocyte Networks Regulate (2006) (0)
752 The apolipoprotein E e4 allele in Parkinson disease with and without Alzheimer lesions (1996) (0)
Nonradioactive PCR sequencing using digoxigenin. (2003) (0)
Correlation between mitochondrial respiratory chain and ubiquitin-proteasome gene expression in the human substantia nigra (2005) (0)
Prof. Dr. med. Dr. med. h.c. Georg W. Kreutzberg (2020) (0)
Glia and inflammation in the Parkinsonian substantia nigra (2009) (0)
Forensic Neuropathology and Associated Neurology (2007) (0)
Developing the field of neurogenetics (2017) (0)
Workshop 5 (2009) (0)
Calcium–axonemal microtubuli interactions underlie mechanism(s) of primary cilia morphological changes (2017) (0)
Artificial intelligence techniques for neuropathological diagnostics and research. (2022) (0)
To the Editor (1998) (0)
Welcoming articles on genotype-dependent clinical features and diagnostics (2021) (0)
Foreword (1993) (0)
Microglia in gemistocytic astrocytomas. Commentary (2007) (0)
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline (2019) (0)
Author Correction: Selective, high-contrast detection of syngeneic glioblastoma in vivo (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Manuel Benedikt Graeber?

Manuel Benedikt Graeber is affiliated with the following schools:

University of Sydney

Manuel Benedikt Graeber's Academic­Influence.com Rankings

Manuel Benedikt Graeber's Degrees

Similar Degrees You Can Earn

Why Is Manuel Benedikt Graeber Influential?

Manuel Benedikt Graeber's Published Works

Published Works

What Schools Are Affiliated With Manuel Benedikt Graeber?

Manuel Benedikt Graeber's AcademicInfluence.com Rankings